Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011 – 2013)

Abstract excerpt

INTRODUCTION: Leucine-rich repeat kinase 2 (LRRK2) is a large (2527 residues) complex multi-domain protein that has GTPase and kinase domains. Autosomal dominant missense mutations in LRRK2 have been found in individuals with Parkinson's disease (PD) and are considered responsible for 1% of all cases of PD. Among the mutations confirmed to contribute to PD pathogenicity, G2019S is the most common cause of PD and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Metabolism, Diabetes, and Cancer
• Share to Parkinson's Disease Mechanisms and Treatments
• Share to Protein Kinase Regulation and GTPase Signaling